FDA Warning Letter — Diamond Palace

Case 514204 — FEI 3013132621

The FDA took a Warning Letter action against Diamond Palace on Jan 5, 2017 (Philadelphia, PA). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Diamond Palace
Date
Jan 5, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Philadelphia, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.